Strategic Collaboration to Address Critical Healthcare Needs and Expand Access to Life-Changing Treatments Riyadh – Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a leading Saudi pharmaceutical company, today announced an exclusive licensing agreement with Polaris, a…
Tabuk Pharmaceuticals Expands Strategic Partnership with HK inno.N to Include Additional MENA Markets for K-CAB® (Tegoprazan)
Riyadh, Saudi Arabia – [May 7 2025] — Tabuk Pharmaceuticals, a leading Saudi pharmaceutical company with a strong regional footprint across the Middle East and North Africa (MENA), announced today the expansion of its strategic collaboration with HK inno.N for the…
Tabuk Pharmaceuticals Partners with Prestige Biopharma for Commercialization of Tuznue™ Trastuzumab Biosimilar in MENA
Riyadh — Tabuk Pharmaceuticals, a leading Saudi pharmaceuticals company, and Prestige Biopharma, a publicly listed company based in Singapore focusing on late-stage clinical development of new antibody therapeutics and biosimilars, today announced an exclusive licensing and distribution agreement for the commercialization…
Tabuk Pharmaceuticals inaugurated its new manufacturing site in Blida, Algeria
As part of its efforts to strengthen its presence and expand its geographical expansion in the MENA region, Tabuk Pharmaceuticals inaugurated a new manufacturing site in in Blida, Algeria. Blida site covers an area of 6,200 square meters and a construction…
Tabuk Pharmaceuticals inaugurated its new state-of-art manufacturing site in Dammam, the Kingdom of Saudi Arabia
As part of its efforts to strengthen its presence and expand its geographical expansion in the MENA region, Tabuk Pharmaceuticals inaugurated a new manufacturing site in the second industrial city of Dammam in the Kingdom of Saudi Arabia to be foreseen…
Tabuk is actively engaged in supporting women’s
Tabuk Pharmaceutical Manufacturing Company has announced plans to increase its female employee intake in the next 5 years by hiring 200-300 additional females in Tabuk, Riyadh, and Dammam to increase their share of the total headcount to 20%. Tabuk’s commitment to…
Tabuk: on pharma’s frontline
Excerpt from the interview with Ismail Bel-Bachir appearing in Venture Magazine, by Elisa Oddone. Boasting a steady annual growth of 25 percent for the past four years, Jordanian-founded pharmaceutical company Tabuk has managed to navigate through the changing business environment in…
Tabuk pharmaceuticals signs exclusive license and supply agreement with aenova holding for diclofenac sodium and omeprazol fixed dose combination pellets
Tabuk Pharmaceutical Manufacturing Company “Tabuk”, one of the leading pharmaceutical companies in the Middle East and North Africa region (MENA) region, has entered into an exclusive license and supply agreement with Aenova Holding, under which Aenova Holding granted to Tabuk an…
Tabuk pharmaceuticals enters into a partnership with cigalah
Tabuk Pharmaceutical Manufacturing Commpany and Cigalah, is a leading healthcare distributor in KSA, announced that they have entered into a partnership under which Tabuk will transfer the rights of second generics of 4 existing Tabuk products to Cigalah. Tabuk will remain…
Tabuk pharmaceuticals enters into a partnership with pfizer in the kingdom of saudi arabia
Tabuk Pharmaceuticals has signed a commercial agreement with Pfizer, the US-based global industry leader. The venture leverages the respective companies’ market leading presence in the Kingdom of Saudi Arabia, to deliver increased value to patients in the Cardiovascular, Central Nervous System,…